PTC Therapeutics | PTCT - Ebit



金融业
股票价格
USD 65.44
资产
USD 3.21B
现金及等价物
USD 508.89M
销售成本
USD 19.92M
流动资产
USD 2.54B
流动负债
USD 776.08M
债务
USD 2.84B
EBIT
USD 146.03M
EBITDA
USD 161.9M
员工
939
EPS每股收益
USD -0.62
股本和储备
USD -191.21M
销售毛利
USD 321.55M
债务利息支出
USD 3.21B
贷款资金
USD 536.27M
市值
USD 5.03B
净收入
USD 83.5M
营业费用
USD 211.54M
营业利润
USD 148.98M
普通股股本
USD 83.33M
PE价格收益
8.76
税前利润
USD -41.09M
销售收入
USD 357.8M
销售和管理费用
USD 80.63M
股票
USD 109.33M
贸易债权人
USD 41.59M
应收帐款人
USD 239.04M


Ebit 更改 日
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Cytokinetics USD -167.09M 12.08M 2026-09
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Novartis USD 5.14B 411M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
TG Therapeutics USD 21.67M 13.12M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09
Xencor USD -36.6M 41.26M 2026-06